Urine and Blood characteristics are present in Table 1 and Table 2. Shapiro-Wilk test indicated the presence of normality (P > 0.05) for FPD, K+, Na+, Cl−, Cr and Urate during 2nd sampling and Urea during 1st sampling in Urine samples and for Glucose, MPV during 2nd sampling, Urea, Urate, Ht, MPV during 1st sampling and K+ during 1st and 2nd sampling in blood samples. All other variables showed an absence of normality (P < 0.05). All non-parametric data transform to normality using log transformation, except for CRP and additional electrolytes in the Blood. Based on this notion, the parametric and non-parametric test is employed.
Table 1
Urine parameter value during 1st and 2nd sampling
Table 1. Participant Urine parameter
|
Participants group
|
Control
|
Test
|
Mean
|
Standard Deviation
|
Mean
|
Standard Deviation
|
Freezing point depression (mK)_1st sampling
|
Female
|
852.75
|
591.82
|
479.40
|
240.33
|
Male
|
1072.00
|
455.10
|
334.44
|
103.97
|
Freezing point depression (mK)_2nd sampling
|
Female
|
752.50
|
287.25
|
858.40
|
380.45
|
Male
|
1000.20
|
362.34
|
1283.44
|
579.44
|
K (mmol/L)_1st sampling
|
Female
|
37.50
|
19.23
|
27.40
|
13.72
|
Male
|
59.20
|
28.58
|
17.56
|
9.61
|
K (mmol/L)_2nd sampling
|
Female
|
23.75
|
8.46
|
38.20
|
18.09
|
Male
|
51.40
|
19.45
|
39.00
|
17.20
|
Na (mmol/L)_1st sampling
|
Female
|
82.25
|
65.51
|
38.40
|
15.42
|
Male
|
99.80
|
48.02
|
23.89
|
8.67
|
Na (mmol/L)_2nd sampling
|
Female
|
103.50
|
57.74
|
68.00
|
25.09
|
Male
|
101.00
|
61.56
|
84.56
|
47.67
|
Cl (mmol/L)_1st sampling
|
Female
|
77.50
|
64.92
|
49.40
|
18.69
|
Male
|
140.80
|
73.65
|
33.56
|
13.00
|
Cl (mmol/L)_2nd sampling
|
Female
|
82.25
|
50.41
|
52.20
|
19.92
|
Male
|
115.60
|
77.35
|
78.89
|
61.76
|
Urea (mmol/L)_1st sampling
|
Female
|
188.50
|
145.42
|
111.40
|
70.96
|
Male
|
210.80
|
85.51
|
80.11
|
44.90
|
Urea (mmol/L)_2nd sampling
|
Female
|
144.50
|
58.03
|
216.00
|
126.16
|
Male
|
212.00
|
70.25
|
370.22
|
188.24
|
Cr (mmol/L)_1st sampling
|
Female
|
13.08
|
13.43
|
4.26
|
4.23
|
Male
|
12.06
|
9.09
|
2.84
|
1.68
|
Cr (mmol/L)_2nd sampling
|
Female
|
8.25
|
1.63
|
9.68
|
5.54
|
Male
|
8.88
|
4.40
|
15.07
|
8.59
|
Urat (mmol/L)_1st sampling
|
Female
|
2.18
|
1.71
|
0.96
|
0.55
|
Male
|
2.02
|
0.86
|
0.78
|
0.32
|
Urat (mmol/L)_2nd sampling
|
Female
|
1.78
|
0.75
|
1.74
|
0.78
|
Male
|
1.82
|
0.53
|
2.74
|
1.24
|
Table 2
Blood parameter value during 1st and 2nd sampling
Table 2. Participant blood parameter
|
Participants group
|
Control
|
Test
|
Mean
|
Standard Deviation
|
Mean
|
Standard Deviation
|
Urea (mmolL)_1st sampling
|
Female
|
3.65
|
1.68
|
3.74
|
0.86
|
Male
|
4.26
|
1.40
|
3.77
|
1.13
|
Urea (mmolL)_2nd sampling
|
Female
|
3.60
|
0.82
|
3.82
|
0.68
|
Male
|
4.32
|
1.43
|
4.51
|
1.67
|
Cr (µmolL)_1st sampling
|
Female
|
72.25
|
9.54
|
61.80
|
4.60
|
Male
|
67.00
|
6.08
|
72.44
|
10.50
|
Cr (µmolL)_2nd sampling
|
Female
|
71.25
|
7.85
|
63.80
|
4.38
|
Male
|
64.80
|
5.45
|
74.11
|
10.40
|
Urat (µmolL)_1st sampling
|
Female
|
245.50
|
18.63
|
263.60
|
32.53
|
Male
|
329.80
|
38.23
|
280.00
|
21.17
|
Urat (µmolL)_2nd sampling
|
Female
|
259.00
|
14.70
|
287.20
|
20.19
|
Male
|
332.20
|
58.98
|
310.22
|
42.42
|
Glucose (mmolL)_1st sampling
|
Female
|
4.05
|
0.26
|
4.20
|
0.16
|
Male
|
4.84
|
0.79
|
4.62
|
0.48
|
Glucose (mmolL)_2nd sampling
|
Female
|
4.25
|
0.24
|
4.46
|
0.30
|
Male
|
4.92
|
0.57
|
4.67
|
0.45
|
CRP (mg/L)_1st sampling
|
Female
|
1.00
|
0.00
|
0.80
|
0.84
|
Male
|
2.80
|
2.59
|
0.67
|
0.50
|
CRP (mg/L)_2nd sampling
|
Female
|
1
|
1
|
1
|
2
|
Male
|
3
|
3
|
1
|
1
|
LE (109/L)_1st sampling
|
Female
|
6.45
|
0.62
|
6.00
|
0.97
|
Male
|
5.86
|
1.71
|
6.86
|
1.70
|
LE (109/L)_2nd sampling
|
Female
|
6.8
|
1.1
|
6.6
|
2.1
|
Male
|
6.0
|
1.4
|
6.6
|
1.3
|
ER (109/L)_1st sampling
|
Female
|
4.48
|
0.36
|
4.64
|
0.18
|
Male
|
4.90
|
0.32
|
4.80
|
0.34
|
ER (109/L)_2nd sampling
|
Female
|
4.5
|
0.4
|
4.7
|
0.3
|
Male
|
4.9
|
0.4
|
4.8
|
0.4
|
Hg (g/L)_1st sampling
|
Female
|
132.00
|
6.78
|
135.20
|
8.14
|
Male
|
144.20
|
14.97
|
141.56
|
11.06
|
Hg (g/L)_2nd sampling
|
Female
|
130
|
8
|
138
|
9
|
Male
|
143
|
14
|
139
|
12
|
Ht_1st sampling
|
Female
|
0.39
|
0.01
|
0.40
|
0.02
|
Male
|
0.43
|
0.04
|
0.42
|
0.03
|
Ht_2nd sampling
|
Female
|
0.39
|
0.02
|
0.41
|
0.02
|
Male
|
0.43
|
0.03
|
0.42
|
0.03
|
MCV (fl)_1st sampling
|
Female
|
88.25
|
6.18
|
86.80
|
3.03
|
Male
|
88.00
|
6.20
|
88.33
|
4.95
|
MCV (fl)_2nd sampling
|
Female
|
88
|
5
|
87
|
3
|
Male
|
89
|
7
|
88
|
5
|
MCH (pg)_1st sampling
|
Female
|
29.50
|
2.08
|
29.00
|
1.00
|
Male
|
29.60
|
2.51
|
29.56
|
2.24
|
MCH (pg)_2nd sampling
|
Female
|
30
|
2
|
30
|
1
|
Male
|
29
|
2
|
29
|
2
|
MCHC (g/L)_1st sampling
|
Female
|
335.00
|
8.21
|
337.20
|
6.02
|
Male
|
334.40
|
5.90
|
334.11
|
8.10
|
MCHC (g/L)_2nd sampling
|
Female
|
333
|
9
|
341
|
5
|
Male
|
328
|
8
|
331
|
10
|
MPV (fl)_1st sampling
|
Female
|
8.75
|
.50
|
8.40
|
0.89
|
Male
|
9.00
|
1.22
|
7.78
|
0.97
|
MPV (fl)_2nd sampling
|
Female
|
9
|
1
|
8
|
1
|
Male
|
9
|
1
|
8
|
1
|
TR (109/L)_1st sampling
|
Female
|
239.75
|
26.70
|
251.60
|
51.57
|
Male
|
261.80
|
31.07
|
264.00
|
52.69
|
TR (109/L)_2nd sampling
|
Female
|
259
|
38
|
269
|
50
|
Male
|
255
|
36
|
275
|
39
|
K (mmolL)_1st sampling
|
Male
|
4.4
|
0.2
|
4.0
|
0.2
|
K (mmolL)_2nd sampling
|
Male
|
4.2
|
0.2
|
4.1
|
0.2
|
Na (µmolL)_1st sampling
|
Male
|
137
|
2
|
134
|
5
|
Na (µmolL)_2nd sampling
|
Male
|
137
|
2
|
136
|
5
|
Cl (µmolL)_1st sampling
|
Male
|
104
|
1
|
100
|
4
|
Cl (µmolL)_2nd sampling
|
Male
|
102
|
1
|
101
|
4
|
Paired T-test revealed a statistically significant difference (P < 0.01, 95% CI), between 1st and 2nd sampling for FPD, Na+, K+, Cr, Urea, Urate in Urine and Urea, Urate, Glu, Ht, TR in Blood. Wilcoxon T-test shows the absence of statistically significant difference (P > 0.05, α = 0.05, 95% CI) for CRP in Blood. Results are confirmed with Mann-Whitney and Kruskal-Wallis test. The difference between T/C group confirm independent T-test for FPD (P < 0.01), K+ (P < 0.05), Na+ (P < 0.01), Cl− (P < 0.05), Cr (P < 0.05), Urate (P < 0.01) and Urea (P < 0.05) in Urine after 1st sampling and K+ (P < 0.01) and Cl− (P < 0.01) after 1st sampling in Blood. Figure 1. shows the difference between test and control group for 1st and 2nd sampling in Blood and Urine. Gender difference confirmed for Urea (P < 0.05) variable after 2nd sampling in Urine and for Urate (P < 0.01/0.05), Glu (P < 0.01/0.05) and Ht (P < 0.01/0.05) after 1st and 2nd sampling and MCHC (P < 0.05) during 2nd sampling in Blood.
The amount of water intake, diseases, usage of drugs and profession type can lead to electrolyte misbalance resulting in quality and interpretation, further prognosis, diagnosis and patient follow-up [10, 11]. In this study, the percentage difference between genders exists for Urea (52.22%) after 2nd sampling in Urine. In Blood for Urate (1st:15.16%; 2nd:14.5%), Glu (1st:13.63%; 2nd:8.7%), Ht (1st and 2nd:7.23%) during 1st and 2nd sampling and MCHC (2.1%) during 2nd sampling. Males have higher values in comparing to females. Sex hormones affect gender differences [12–15]. Female sex hormones (Estrogen) regulate the activity of glucose and urate transporters (ABCG2 and SLC2A9), having different transporter expression (transcription, post-translational modification), localization and activity [12, 13]. Male sex hormones (Testosterone) affect MCHC and Ht level through the increase of erythropoietin, reduction of ferritin and hepcidin [14]. Testosterone influence protein metabolism and the urea cycle [15].
Drinking more water improves kidney function and clearance of toxins by glomerular filtration, tubular secretion, and activation of various degradative metabolic pathways [17]. Results indicate that water intake influence Urine [FPD (86.5%), K+ (81.7%), Na+ (104.1%), Cl- (97.37%), Urea (75.34%), Cr (116.45%), Urat (89.65%)] and Blood [K+ (9.5%), Cl- (3.92%)] during 1st sampling. There is a link between water intake and homeostatic mechanisms to maintain water balance and health outcomes. Urine osmolarity depends on cations, Na+, K+, NH4+, anions and Urea, whereas FPD enables estimation of urine osmolality [18, 19]. Freezing point depression as a colligative property depends on the molality of the solute [20]. Renal Cr excretion level depends on the glomerular filtration rate, proximal tubular secretion and OCT-2 transporter [21, 22]. Higher water intake after 3. days causes a decrease of uric acid, up-regulation of GLUT9 and URAT1 and down-regulation of ABCG2 and OAT1, while after 7. days affect NPT1 down-regulation in hyperuricemia mice [23]. Urate level depends on transport proteins (URAT1 and GLUT9), uricase inactivation and possible change of the intestinal microbiota [23]. Production of concentrated Urine requires interactions among the nephron segments and vasculature in the kidney medulla [24]. Arginine vasopressin (AVP) is a key molecule in water homeostasis. Increase water intake, decrease AVP, reduce risk of renal and metabolic diseases and improve health outcome [24]. Vasopressin regulates urea transport acutely by increasing UT-A1 phosphorylation and the apical plasma-membrane accumulation of UT-A1 through two cAMP-dependent pathways [25]. Glut9 plays a major role in urate homeostasis by its dual role in urate handling in the kidney and uptake in the liver [26]. Small water intake can lead to dehydration, activation of the renin-angiotensin system (RAS) through angiotensin receptors and subsequent activation of signalling molecules, protein kinase C, reactive oxygen species, MAP kinase pathway mediated with angiotensin (27). Prolactin, aldosterone and antidiuretic hormone, influence water metabolism and electrolyte balance [28–37].
Results show higher concentration percentage increase in variables from Urine [FDP (68%), Na+ (62.96%), K+ (21.88%), Cr (65.2%), Urat (69.2%), Urea (96.27%)] in comparing to Blood [Urea (10.5%), Urate (7.1%), Glu (2.2%), Ht (2.43%), TR (3.9%)] between 1st and 2nd sampling of 7th and 9th day of water intake. Studies indicate that daily water intake in healthy Japanese adults’ decrease blood pressure, Ht, Urine gravity and a rise in body temperature [38]. Lower and steady daily water intake increase Cr, Cortisol, Urea, Uric acid, Na+, Hg; decrease CRP, and have no change in Ht, active rennin, aldosterone and plasma osmolality [39–42].
Ex vivo cellular injury, disintegration, cellular granule release and protease activation causes alterations of cell release in vitro after sampling [1]. Hydration biomarkers in 24h urine correlate with daily total fluid intake volume in sedentary adults in free-living conditions [43]. Literature findings follow the results of the study. Explain differences in concentration changes of healthy participants, due to water intake and sample sampling.